Literature DB >> 26059845

Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations.

Petra Dusatkova1, Roland Pfäffle2, Milton R Brown3, Natallia Akulevich4, Ivo J P Arnhold5, Maria A Kalina6, Karolina Kot7, Ciril Krzisnik8, Manuel C Lemos9, Jana Malikova1, Ruta Navardauskaite10, Barbora Obermannova1, Zuzana Pribilincova11, Agnes Sallai12, Gordana Stipancic13, Rasa Verkauskiene10, Ondrej Cinek1, Werner F Blum2, John S Parks3, Frederic Austerlitz14, Jan Lebl1.   

Abstract

Two variants (c.[301_302delAG];[301_302delAG] and c.[150delA];[150delA]) in the PROP1 gene are the most common genetic causes of recessively inherited combined pituitary hormones deficiency (CPHD). Our objective was to analyze in detail the origin of the two most prevalent variants. In the multicentric study were included 237 patients with CPHD and their 15 relatives carrying c.[301_302delAG];[301_302delAG] or c.[150delA];[150delA] or c.[301_302delAG];[ 150delA]. They originated from 21 different countries worldwide. We genotyped 21 single-nucleotide variant markers flanking the 9.6-Mb region around the PROP1 gene that are not in mutual linkage disequilibrium in the general populations--a finding of a common haplotype would be indicative of ancestral origin of the variant. Haplotypes were reconstructed by Phase and Haploview software, and the variant age was estimated using an allelic association method. We demonstrated the ancestral origin of both variants--c.[301_302delAG] was carried on 0.2 Mb-long haplotype in a majority of European patients arising ~101 generations ago (confidence interval 90.1-116.4). Patients from the Iberian Peninsula displayed a different haplotype, which was estimated to have emerged 23.3 (20.1-29.1) generations ago. Subsequently, the data indicated that both the haplotypes were transmitted to Latin American patients ~13.8 (12.2-17.0) and 16.4 (14.4-20.1) generations ago, respectively. The c.[150delA] variant that was carried on a haplotype spanning about 0.3 Mb was estimated to appear 43.7 (38.4-52.7) generations ago. We present strong evidence that the most frequent variants in the PROP1 gene are not a consequence of variant hot spots as previously assumed, but are founder variants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26059845      PMCID: PMC4755373          DOI: 10.1038/ejhg.2015.126

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

Review 1.  The spectrum of hypopituitarism caused by PROP1 mutations.

Authors:  Sushil Mody; Milton R Brown; John S Parks
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2002-09       Impact factor: 4.690

2.  Detecting population growth, selection and inherited fertility from haplotypic data in humans.

Authors:  Frédéric Austerlitz; Luba Kalaydjieva; Evelyne Heyer
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

3.  DMLE+: Bayesian linkage disequilibrium gene mapping.

Authors:  Jeff P Reeve; Bruce Rannala
Journal:  Bioinformatics       Date:  2002-06       Impact factor: 6.937

4.  Estimating the age of rare disease mutations: the example of Triple-A syndrome.

Authors:  E Genin; A Tullio-Pelet; F Begeot; S Lyonnet; L Abel
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

5.  Estimating the age of alleles by use of intraallelic variability.

Authors:  M Slatkin; B Rannala
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

6.  Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes.

Authors:  Maria Geralda F Osorio; Suemi Marui; Alexander A L Jorge; Ana C Latronico; Leonard S S Lo; Claudia C Leite; Vivian Estefan; Berenice B Mendonca; Ivo J P Arnhold
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

7.  Simple repeat DNA is not replicated simply.

Authors:  R I Richards; G R Sutherland
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency.

Authors:  O V Fofanova; N Takamura; E Kinoshita; J S Parks; M R Brown; V A Peterkova; O V Evgrafov; N P Goncharov; A A Bulatov; I I Dedov; S Yamashita
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

9.  Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism.

Authors:  M W Sornson; W Wu; J S Dasen; S E Flynn; D J Norman; S M O'Connell; I Gukovsky; C Carrière; A K Ryan; A P Miller; L Zuo; A S Gleiberman; B Andersen; W G Beamer; M G Rosenfeld
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

Review 10.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Shaw; Andrew Phillips; David N Cooper
Journal:  Hum Genet       Date:  2014-01       Impact factor: 4.132

View more
  11 in total

1.  Genetic analysis of adult Slovenian patients with combined pituitary hormone deficiency.

Authors:  Katica Bajuk Studen; Magdalena Avbelj Stefanija; Alexandru Saveanu; Anne Barlier; Thierry Brue; Marija Pfeifer
Journal:  Endocrine       Date:  2019-05-15       Impact factor: 3.633

Review 2.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

Review 3.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

4.  Genetic screening of regulatory regions of pituitary transcription factors in patients with idiopathic pituitary hormone deficiencies.

Authors:  Melitza Elizabeth; Anita C S Hokken-Koelega; Joyce Schuilwerve; Robin P Peeters; Theo J Visser; Laura C G de Graaff
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  Combined pituitary hormone deficiency due to gross deletions in the POU1F1 (PIT-1) and PROP1 genes.

Authors:  Eleonore Bertko; Jürgen Klammt; Petra Dusatkova; Mithat Bahceci; Nazli Gonc; Louise Ten Have; Nurgun Kandemir; Georg Mansmann; Barbora Obermannova; Wilma Oostdijk; Heike Pfäffle; Denise Rockstroh-Lippold; Marina Schlicke; Alpaslan Kemal Tuzcu; Roland Pfäffle
Journal:  J Hum Genet       Date:  2017-03-30       Impact factor: 3.172

6.  SEMA3A and IGSF10 Are Novel Contributors to Combined Pituitary Hormone Deficiency (CPHD).

Authors:  Bartlomiej Budny; Tomasz Zemojtel; Malgorzata Kaluzna; Pawel Gut; Marek Niedziela; Monika Obara-Moszynska; Barbara Rabska-Pietrzak; Katarzyna Karmelita-Katulska; Marek Stajgis; Urszula Ambroziak; Tomasz Bednarczuk; Elzbieta Wrotkowska; Ewelina Bukowska-Olech; Aleksander Jamsheer; Marek Ruchala; Katarzyna Ziemnicka
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-16       Impact factor: 5.555

7.  Next generation sequencing panel based on single molecule molecular inversion probes for detecting genetic variants in children with hypopituitarism.

Authors:  María I Pérez Millán; Sebastian A Vishnopolska; Alexandre Z Daly; Juan P Bustamante; Adriana Seilicovich; Ignacio Bergadá; Débora Braslavsky; Ana C Keselman; Rosemary M Lemons; Amanda H Mortensen; Marcelo A Marti; Sally A Camper; Jacob O Kitzman
Journal:  Mol Genet Genomic Med       Date:  2018-05-08       Impact factor: 2.183

8.  Genetic diagnosis of congenital hypopituitarism by a target gene panel: novel pathogenic variants in GLI2, OTX2 and GHRHR.

Authors:  Marilena Nakaguma; Fernanda A Correa; Lucas S Santana; Anna F F Benedetti; Ricardo V Perez; Martha K P Huayllas; Mirta B Miras; Mariana F A Funari; Antonio M Lerario; Berenice B Mendonca; Luciani R S Carvalho; Alexander A L Jorge; Ivo J P Arnhold
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

9.  Comprehensive Identification of Pathogenic Gene Variants in Patients With Neuroendocrine Disorders.

Authors:  Sebastian Alexis Vishnopolska; Maria Florencia Mercogliano; Maria Andrea Camilletti; Amanda Helen Mortensen; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Federico Olivieri; Lucas Miranda; Roxana Marino; Pablo Ramírez; Natalia Pérez Garrido; Helen Patiño Mejia; Marta Ciaccio; Maria Isabel Di Palma; Alicia Belgorosky; Marcelo Adrian Martí; Jacob Otto Kitzman; Sally Ann Camper; Maria Ines Pérez-Millán
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 6.134

10.  Mutations Within the Transcription Factor PROP1 in a Cohort of Turkish Patients with Combined Pituitary Hormone Deficiency

Authors:  Fatma Derya Bulut; Semine Özdemir Dilek; Damla Kotan; Eda Mengen; Fatih Gürbüz; Bilgin Yüksel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.